Pharmacognosy Communications,2018,8,3,96.
Published:July 2018


I.E. Cock1,2*


1Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

2School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.


Dear readers and authors,

I am pleased to bring you volume 8, issue 3 of Pharmacognosy Communications. In this issue we present new research examining the pharmacognosy of several important medicinal plants including the antibacterial and antifungal activity of the Asia medicinal plant Ajuga bracteosa. This species is used in a diverse array of Asian traditional medicine systems (including traditional Chinese medicine and Ayuverda) to treat a variety of inflammatory conditions including gout, rheumatism and amenorrhea. It has also been used for treatment of diabetes, malaria, and cancer. We also present a pharmacognostic study on Delonix regia. This species has an impressive range of medicinal and biological properties including uses for the treatment of constipation, inflammation, arthritis, hemiplagia, gynecological disorders, diabetes and rheumatism. An Indonesian study examined the phytochemistry of Myristica fragrans mace extracts and reported good antioxidant and antibacterial activity. Furthermore, the extracts inhibited α-glucosidase, indicating that they may also be useful in the treatment of diabetes. A further study examines the antioxidant properties of Mangifera indica leaves. We also present study which used an in silico docking model to highlight some phytochemicals with potential COX-2 and LOX-3 inhibitory potential. In particular, gallic acid and epicatechinwere determined to be promising leads. That study then confirmed the potential of both of these compounds using enzyme inhibition assays. Gallic acid was also the focus of another study which examined the pharmacokinetics of gallic acid following topical application of ointments containing Chrysophyllum cainito and Mimusops elengi in rats.


Cite This Article

Vancouver Style :: Cock IE. Editorial. Pharmacognosy Communications. 2018;8(3):96.  (302.39 KB)
MLA Style: Cock IE. Editorial. Pharmacognosy Communications. 2018;8(3):96.  (302.39 KB)
CSE Style: Cock IE. Editorial. Pharmacognosy Communications. 2018;8(3):96.  (302.39 KB)
APA Style: Cock IE. Editorial. Pharmacognosy Communications. 2018;8(3):96.  (302.39 KB)

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.